These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19667532)

  • 1. The protective effects of leukotriene modifiers in aspirin-induced asthma.
    Israel E
    Postgrad Med; 2000 Sep; 108(4 Suppl):40-4. PubMed ID: 19667532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma.
    Bisgaard H
    Allergy; 2001; 56 Suppl 66():7-11. PubMed ID: 11421935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics.
    Dahlén B; Nizankowska E; Szczeklik A; Zetterström O; Bochenek G; Kumlin M; Mastalerz L; Pinis G; Swanson LJ; Boodhoo TI; Wright S; Dubé LM; Dahlén SE
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1187-94. PubMed ID: 9563738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathogenesis and management of aspirin-intolerant asthma.
    Obase Y; Matsuse H; Shimoda T; Haahtela T; Kohno S
    Treat Respir Med; 2005; 4(5):325-36. PubMed ID: 16137190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukotriene modifiers to prevent aspirin-provoked respiratory reactions in asthmatics.
    Volkman JA; Pontikes PJ
    Ann Pharmacother; 2002 Sep; 36(9):1457-61. PubMed ID: 12196067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asthma pharmacotherapy: an update on leukotriene treatments.
    Trinh HKT; Lee SH; Cao TBT; Park HS
    Expert Rev Respir Med; 2019 Dec; 13(12):1169-1178. PubMed ID: 31544544
    [No Abstract]   [Full Text] [Related]  

  • 7. Efficacy of leukotriene receptor antagonist in bronchial hyperresponsiveness and hypersensitivity to analgesic in aspirin-intolerant asthma.
    Yoshida S; Sakamoto H; Ishizaki Y; Onuma K; Shoji T; Nakagawa H; Hasegawa H; Nakabayashi M; Amayasu H
    Clin Exp Allergy; 2000 Jan; 30(1):64-70. PubMed ID: 10606932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The role of leukotrienes in inflammation and leukotriene inhibitors].
    Kupczyk M; Kuna P
    Pol Merkur Lekarski; 1999 Sep; 7(39):85-93. PubMed ID: 10598480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of leukotrienes in the management of asthma: biology and clinical therapy.
    Leff AR
    Annu Rev Med; 2001; 52():1-14. PubMed ID: 11160764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leukotrienes, leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma: an update. Part II: clinical studies with leukotriene receptor antagonists and leukotriene synthesis inhibitors in asthma.
    Devillier P; Baccard N; Advenier C
    Pharmacol Res; 1999 Jul; 40(1):15-29. PubMed ID: 10378986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic properties of leukotriene receptor antagonists.
    Nicosia S
    Monaldi Arch Chest Dis; 1999 Jun; 54(3):242-6. PubMed ID: 10441979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of leukotriene receptor antagonists (LTRAs) as complementary therapy in asthma.
    Bjermer L; Diamant Z
    Monaldi Arch Chest Dis; 2002 Feb; 57(1):76-83. PubMed ID: 12174707
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory properties of montelukast, a leukotriene receptor antagonist in patients with asthma and nasal polyposis.
    Schäper C; Noga O; Koch B; Ewert R; Felix SB; Gläser S; Kunkel G; Gustavus B
    J Investig Allergol Clin Immunol; 2011; 21(1):51-8. PubMed ID: 21370724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin and asthma.
    Babu KS; Salvi SS
    Chest; 2000 Nov; 118(5):1470-6. PubMed ID: 11083703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cough, asthma, and cysteinyl-leukotrienes.
    Niimi A
    Pulm Pharmacol Ther; 2013 Oct; 26(5):514-9. PubMed ID: 23774534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective cyclooxygenase-2 inhibitor cross-reactivity in aspirin-exacerbated respiratory disease.
    Umemoto J; Tsurikisawa N; Nogi S; Iwata K; Oshikata C; Tatsuno S; Tanimoto H; Sekiya K; Tsuburai T; Mitomi H; Akiyama K
    Allergy Asthma Proc; 2011; 32(3):259-61. PubMed ID: 21703104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment heterogeneity in asthma: genetics of response to leukotriene modifiers.
    Lima JJ
    Mol Diagn Ther; 2007; 11(2):97-104. PubMed ID: 17397245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukotrienes in respiratory disease.
    McMillan RM
    Paediatr Respir Rev; 2001 Sep; 2(3):238-44. PubMed ID: 12052325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum phospholipase A2 activity in patients with aspirin-induced asthma].
    Toyoshima M; Sato A; Taniguchi M; Imokawa S; Nakazawa K; Hayakawa H; Chida K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Jul; 33(7):691-4. PubMed ID: 7563992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analgesics and asthma.
    Szczeklik A; Nizankowska E; Mastalerz L; Szabo Z
    Am J Ther; 2002; 9(3):233-43. PubMed ID: 11941383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.